{"DataElement":{"publicId":"7477418","version":"1","preferredName":"Genetic Modification Performed Type","preferredDefinition":"A description of the genetic modification performed.","longName":"5152073v1.0:7477410v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5152073","version":"1","preferredName":"Genetic Modification Performed","preferredDefinition":"Techniques used for deliberately altering the genetic material of an organism in order to make them capable of making new substances or performing new or different functions._Executed and carried through to completion.","longName":"5152071v1.0:2241241v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"5152071","version":"1","preferredName":"Organism Modification","preferredDefinition":"Techniques used for deliberately altering the genetic material of an organism in order to make them capable of making new substances or performing new or different functions.","longName":"C22489","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Organism Modification","conceptCode":"C22489","definition":"Techniques used for deliberately altering the genetic material of an organism in order to make them capable of making new substances or performing new or different functions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2D3F5AC2-D5C2-62EC-E050-BB89AD434FE6","latestVersionIndicator":"Yes","beginDate":"2016-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-04","modifiedBy":"ONEDATA","dateModified":"2016-03-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2241241","version":"1","preferredName":"Performed","preferredDefinition":"Performed; carried out.","longName":"C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FA7953-8839-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435033","version":"1","preferredName":"Techniques","preferredDefinition":"A practiced and regimented skill or series of actions.","longName":"C16847","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87DA-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2D3F5AC2-D5D0-62EC-E050-BB89AD434FE6","latestVersionIndicator":"Yes","beginDate":"2016-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-04","modifiedBy":"NYCHM","dateModified":"2016-07-25","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7477410","version":"1","preferredName":"Gene Modification Type","preferredDefinition":"Any gene manipulation method used to generate a product with an altered sequence, structure, or conformation._Something distinguishable as an identifiable class based on common qualities.","longName":"7477410v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other genetic manipulation","valueDescription":"Other Gene Modification","ValueMeaning":{"publicId":"7477411","version":"1","preferredName":"Other Gene Modification","longName":"7477411","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Any gene manipulation method used to generate a product with an altered sequence, structure, or conformation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gene Modification","conceptCode":"C126104","definition":"Any gene manipulation method used to generate a product with an altered sequence, structure, or conformation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2590796-3054-0E81-E053-4EBD850AB8AA","latestVersionIndicator":"Yes","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA","dateModified":"2020-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2590796-306D-0E81-E053-4EBD850AB8AA","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA","dateModified":"2020-10-23","deletedIndicator":"No"},{"value":"T-cell receptor","valueDescription":"T-Cell Receptor","ValueMeaning":{"publicId":"4385453","version":"1","preferredName":"T-Cell Receptor","longName":"4385453","preferredDefinition":"Heterodimeric antigen receptors present on the surface of T-cells.  Two T-cell antigen receptors have been identified, consisting of heterodimeric 40-55 kD Ig-like alpha/beta or gamma/delta integral membrane glycoproteins.  Genes for TCR alpha, beta, gamma, and delta subunits are assembled during T-cell development by somatic rearrangement of germline gene segments, resembling B-cell Ig genes in their mechanisms of diversity generation and activation of expression.  Alpha/beta heterodimers are found on helper and cytotoxic T-cells and are specific for antigenic peptides presented by MHC gene products.  T-cells expressing gamma/delta heterodimers directly recognize proteins and non-proteinacious phospho-ligands.  T-cell receptors are non-covalently associated with CD3, forming the TCR-CD3 complex.  TCRs activate MAPKs and JNK1 through the CD3 antigens, the adaptor protein LAT, and tyrosine kinases LCK and ZAP70.  (from OMIM and NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Cell Receptor","conceptCode":"C17065","definition":"Heterodimeric antigen receptors present on the surface of T-cells.  Two T-cell antigen receptors have been identified, consisting of heterodimeric 40-55 kD Ig-like alpha/beta or gamma/delta integral membrane glycoproteins.  Genes for TCR alpha, beta, gamma, and delta subunits are assembled during T-cell development by somatic rearrangement of germline gene segments, resembling B-cell Ig genes in their mechanisms of diversity generation and activation of expression.  Alpha/beta heterodimers are found on helper and cytotoxic T-cells and are specific for antigenic peptides presented by MHC gene products.  T-cells expressing gamma/delta heterodimers directly recognize proteins and non-proteinacious phospho-ligands.  T-cell receptors are non-covalently associated with CD3, forming the TCR-CD3 complex.  TCRs activate MAPKs and JNK1 through the CD3 antigens, the adaptor protein LAT, and tyrosine kinases LCK and ZAP70.  (from OMIM and NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE3DCA1E-C67A-7605-E040-BB89AD4320BD","latestVersionIndicator":"Yes","beginDate":"2014-07-15","endDate":null,"createdBy":"COLBERTM","dateCreated":"2014-07-15","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2590796-3077-0E81-E053-4EBD850AB8AA","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA","dateModified":"2020-10-23","deletedIndicator":"No"},{"value":"Suicide gene","valueDescription":"Suicide Gene","ValueMeaning":{"publicId":"6034142","version":"1","preferredName":"Suicide Gene","longName":"6034142","preferredDefinition":"A gene which will cause a cell to kill itself, typically through interaction with a prodrug.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Suicide Gene","conceptCode":"C132840","definition":"A gene which will cause a cell to kill itself, typically through interaction with a prodrug.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F25F44F-CCF9-032E-E053-F662850AB1FB","latestVersionIndicator":"Yes","beginDate":"2017-11-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2590796-3081-0E81-E053-4EBD850AB8AA","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA","dateModified":"2020-10-23","deletedIndicator":"No"},{"value":"Chimeric Antigen Receptor (CAR)","valueDescription":"Chimeric Antigen Receptor","ValueMeaning":{"publicId":"5156182","version":"1","preferredName":"Chimeric Antigen Receptor","longName":"5156182","preferredDefinition":"A cell-surface receptor that has been engineered to combine novel features and specificities from various sources in order to enhance its antigen specificity. Engineered T-cells or B-cells will produce the specialized receptor that will be capable of binding to an epitope on its target cell.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chimeric Antigen Receptor","conceptCode":"C126108","definition":"A cell-surface receptor that has been engineered to combine novel features and specificities from various sources in order to enhance its antigen specificity. Engineered T-cells or B-cells will produce the specialized receptor that will be capable of binding to an epitope on its target cell.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E18BFE4-8FFF-CA26-E050-BB89AD4332A4","latestVersionIndicator":"Yes","beginDate":"2016-03-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2590796-308B-0E81-E053-4EBD850AB8AA","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA","dateModified":"2020-10-23","deletedIndicator":"No"},{"value":"Gene editing","valueDescription":"Gene Modification","ValueMeaning":{"publicId":"7477412","version":"1","preferredName":"Gene Modification","longName":"7477412","preferredDefinition":"Any gene manipulation method used to generate a product with an altered sequence, structure, or conformation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gene Modification","conceptCode":"C126104","definition":"Any gene manipulation method used to generate a product with an altered sequence, structure, or conformation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2590796-3095-0E81-E053-4EBD850AB8AA","latestVersionIndicator":"Yes","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA","dateModified":"2020-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2590796-30AE-0E81-E053-4EBD850AB8AA","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA","dateModified":"2020-10-23","deletedIndicator":"No"},{"value":"Other non-viral transfection","valueDescription":"Other Negation Viral Transfection","ValueMeaning":{"publicId":"7477413","version":"1","preferredName":"Other Negation Viral Transfection","longName":"7477413","preferredDefinition":"Different than the one(s) previously specified or mentioned.: An operation in which a term denies or inverts the meaning of another term or construction.: Having to do with a virus.: The process of introduction of DNA into a recipient eukaryote cell and its subsequent integration into the recipient cell's chromosomal DNA, so that the cells or progeny may express the integrated donor gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Viral","conceptCode":"C27985","definition":"Having to do with a virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Transfection","conceptCode":"C17209","definition":"The process of introduction of DNA into a recipient eukaryote cell and its subsequent integration into the recipient cell's chromosomal DNA, so that the cells or progeny may express the integrated donor gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2590796-30B8-0E81-E053-4EBD850AB8AA","latestVersionIndicator":"Yes","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA","dateModified":"2020-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2590796-30D1-0E81-E053-4EBD850AB8AA","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA","dateModified":"2020-10-23","deletedIndicator":"No"},{"value":"Electroporation","valueDescription":"Electroporation","ValueMeaning":{"publicId":"7477414","version":"1","preferredName":"Electroporation","longName":"7477414","preferredDefinition":"A procedure in which in which an electrical field is applied to cells for the purpose of increasing the permeability of the cell membrane, allowing chemicals, drugs, or DNA to be introduced into the cell.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Electroporation","conceptCode":"C15707","definition":"A procedure in which in which an electrical field is applied to cells for the purpose of increasing the permeability of the cell membrane, allowing chemicals, drugs, or DNA to be introduced into the cell.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2590796-30DB-0E81-E053-4EBD850AB8AA","latestVersionIndicator":"Yes","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA","dateModified":"2020-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2590796-30F4-0E81-E053-4EBD850AB8AA","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA","dateModified":"2020-10-23","deletedIndicator":"No"},{"value":"Transposon","valueDescription":"Transposon","ValueMeaning":{"publicId":"7477415","version":"1","preferredName":"Transposon","longName":"7477415","preferredDefinition":"A genetic element that is able to move from one genomic position to another.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transposon","conceptCode":"C95942","definition":"A genetic element that is able to move from one genomic position to another.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2590796-3100-0E81-E053-4EBD850AB8AA","latestVersionIndicator":"Yes","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA","dateModified":"2020-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2590796-3119-0E81-E053-4EBD850AB8AA","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA","dateModified":"2020-10-23","deletedIndicator":"No"},{"value":"Retrovirus","valueDescription":"Retroviridae","ValueMeaning":{"publicId":"7477416","version":"1","preferredName":"Retroviridae","longName":"7477416","preferredDefinition":"A family of viruses that possess RNA-dependent DNA polymerases (reverse transcriptases) and contain two identical molecules of positive sense, single-stranded RNA of high molecular weight.  This RNA serves as a template for the synthesis of a complementary DNA, which may be integrated into the host DNA. Virions are enveloped.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Retroviridae","conceptCode":"C14268","definition":"A family of viruses that possess RNA-dependent DNA polymerases (reverse transcriptases) and contain two identical molecules of positive sense, single-stranded RNA of high molecular weight.  This RNA serves as a template for the synthesis of a complementary DNA, which may be integrated into the host DNA. Virions are enveloped.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2590796-3125-0E81-E053-4EBD850AB8AA","latestVersionIndicator":"Yes","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA","dateModified":"2020-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2590796-313E-0E81-E053-4EBD850AB8AA","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA","dateModified":"2020-10-23","deletedIndicator":"No"},{"value":"Lentivirus","valueDescription":"Lentivirus","ValueMeaning":{"publicId":"7477417","version":"1","preferredName":"Lentivirus","longName":"7477417","preferredDefinition":"A genus of the family Retroviridae consisting of non-oncogenic retroviruses that produce multi-organ diseases characterized by long incubation periods and persistent infection. Lentiviruses are unique in that they contain open reading frames (ORFs) between the pol and env genes and in the 3' env region. Five serogroups are recognized, reflecting the mammalian hosts with which they are associated. HIV-1 is the type species.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lentivirus","conceptCode":"C14290","definition":"A genus of the family Retroviridae consisting of non-oncogenic retroviruses that produce multi-organ diseases characterized by long incubation periods and persistent infection. Lentiviruses are unique in that they contain open reading frames (ORFs) between the pol and env genes and in the 3' env region. Five serogroups are recognized, reflecting the mammalian hosts with which they are associated. HIV-1 is the type species.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2590796-314A-0E81-E053-4EBD850AB8AA","latestVersionIndicator":"Yes","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA_WA","dateModified":"2024-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2590796-3163-0E81-E053-4EBD850AB8AA","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA","dateModified":"2020-10-23","deletedIndicator":"No"},{"value":"Uknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C89463B9-E0C9-7894-E053-4EBD850A83C1","beginDate":"2021-08-02","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-08-02","modifiedBy":"ONEDATA","dateModified":"2021-08-02","deletedIndicator":"No"},{"value":"Other methodology","valueDescription":"Other Methodology","ValueMeaning":{"publicId":"7755554","version":"1","preferredName":"Other Methodology","longName":"7755554","preferredDefinition":"Different than the one(s) previously specified or mentioned.: The system of methods followed in a particular discipline.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Methodology","conceptCode":"C86572","definition":"The system of methods followed in a particular discipline.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C89463B9-E0D6-7894-E053-4EBD850A83C1","latestVersionIndicator":"Yes","beginDate":"2021-08-02","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-08-02","modifiedBy":"ONEDATA","dateModified":"2021-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C89463B9-E0EF-7894-E053-4EBD850A83C1","beginDate":"2021-08-02","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-08-02","modifiedBy":"ONEDATA","dateModified":"2021-08-02","deletedIndicator":"No"},{"value":"Zinc finger nucleases (ZFNs)","valueDescription":"Zinc Finger Nuclease","ValueMeaning":{"publicId":"7755555","version":"1","preferredName":"Zinc Finger Nuclease","longName":"7755555","preferredDefinition":"A class of artificial DNA endonucleases that consists of an engineered zinc finger protein fused to the catalytic cleavage domain of the FokI restriction enzyme.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Zinc Finger Nuclease","conceptCode":"C180580","definition":"A class of artificial DNA endonucleases that consists of an engineered zinc finger protein fused to the catalytic cleavage domain of the FokI restriction enzyme.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C89463B9-E0FB-7894-E053-4EBD850A83C1","latestVersionIndicator":"Yes","beginDate":"2021-08-02","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-08-02","modifiedBy":"ONEDATA","dateModified":"2021-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C89463B9-E114-7894-E053-4EBD850A83C1","beginDate":"2021-08-02","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-08-02","modifiedBy":"ONEDATA","dateModified":"2021-08-02","deletedIndicator":"No"},{"value":"Transcription activator-like effector nucleases (TALENs)","valueDescription":"Transcription Activator-like Effector Nuclease","ValueMeaning":{"publicId":"7755556","version":"1","preferredName":"Transcription Activator-like Effector Nuclease","longName":"7755556","preferredDefinition":"A class of custom, sequence-specific DNA endonucleases created by fusing an engineered transcription activator-like effector protein to the catalytic cleavage domain of the FokI restriction enzyme.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transcription Activator-like Effector Nuclease","conceptCode":"C180579","definition":"A class of custom, sequence-specific DNA endonucleases created by fusing an engineered transcription activator-like effector protein to the catalytic cleavage domain of the FokI restriction enzyme.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C89463B9-E120-7894-E053-4EBD850A83C1","latestVersionIndicator":"Yes","beginDate":"2021-08-02","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-08-02","modifiedBy":"ONEDATA","dateModified":"2021-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C89463B9-E139-7894-E053-4EBD850A83C1","beginDate":"2021-08-02","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-08-02","modifiedBy":"ONEDATA","dateModified":"2021-08-02","deletedIndicator":"No"},{"value":"Cas protein","valueDescription":"Cas9 Protein","ValueMeaning":{"publicId":"7755557","version":"1","preferredName":"Cas9 Protein","longName":"7755557","preferredDefinition":"CRISPR (clustered regularly interspaced short palindromic repeat)-associated protein 9 (160 kDa) is encoded by the Streptococcus pyogenes CAS9 gene. This protein is involved in the adaptive immune system of Streptococcus pyogenes. It has been adapted for use in targeted base editing.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cas9 Protein","conceptCode":"C180578","definition":"CRISPR (clustered regularly interspaced short palindromic repeat)-associated protein 9 (160 kDa) is encoded by the Streptococcus pyogenes CAS9 gene. This protein is involved in the adaptive immune system of Streptococcus pyogenes. It has been adapted for use in targeted base editing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C89463B9-E145-7894-E053-4EBD850A83C1","latestVersionIndicator":"Yes","beginDate":"2021-08-02","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-08-02","modifiedBy":"ONEDATA","dateModified":"2021-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C89463B9-E15E-7894-E053-4EBD850A83C1","beginDate":"2021-08-02","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-08-02","modifiedBy":"ONEDATA","dateModified":"2021-08-02","deletedIndicator":"No"},{"value":"Base editor","valueDescription":"Base Editing","ValueMeaning":{"publicId":"7755558","version":"1","preferredName":"Base Editing","longName":"7755558","preferredDefinition":"A technique for the direct conversion of a specific DNA base into another at a targeted genomic locus. This technique uses a Cas nickase, or Cas fused to a deaminase, that makes the edit and a guide RNA that targets Cas to a specific locus. Cytosine base editors mediate a C to T change and adenine base editors mediate an A to G change.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Base Editing","conceptCode":"C180577","definition":"A technique for the direct conversion of a specific DNA base into another at a targeted genomic locus. This technique uses a Cas nickase, or Cas fused to a deaminase, that makes the edit and a guide RNA that targets Cas to a specific locus. Cytosine base editors mediate a C to T change and adenine base editors mediate an A to G change.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C89463B9-E16A-7894-E053-4EBD850A83C1","latestVersionIndicator":"Yes","beginDate":"2021-08-02","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-08-02","modifiedBy":"ONEDATA","dateModified":"2021-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C89463B9-E183-7894-E053-4EBD850A83C1","beginDate":"2021-08-02","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-08-02","modifiedBy":"ONEDATA","dateModified":"2021-08-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435033","version":"1","preferredName":"Techniques","preferredDefinition":"A practiced and regimented skill or series of actions.","longName":"C16847","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87DA-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7477409","version":"1","preferredName":"Gene Modification Type","preferredDefinition":"Any gene manipulation method used to generate a product with an altered sequence, structure, or conformation.:Something distinguishable as an identifiable class based on common qualities.","longName":"C126104:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gene Modification","conceptCode":"C126104","definition":"Any gene manipulation method used to generate a product with an altered sequence, structure, or conformation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2590796-302A-0E81-E053-4EBD850AB8AA","latestVersionIndicator":"Yes","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA","dateModified":"2020-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2590796-303B-0E81-E053-4EBD850AB8AA","latestVersionIndicator":"Yes","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"MALUMK","dateModified":"2021-08-02","changeDescription":"Released. 01/28/2021 KMM. PVs added for 2003r1. 08/02/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CTP_CPM_gene_manip_type","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the genetic modifica","type":"Preferred Question Text","description":"What was the genetic modification performed type?","url":null,"context":"NHLBI"},{"name":"Specify the type(s) of genetic manipulation","type":"Application Standard Question Text","description":"Specify the type(s) of genetic manipulation","url":null,"context":"NHLBI"},{"name":"Specify the type(s) of genetic manipulation","type":"Alternate Question Text","description":"Specify the type(s) of genetic manipulation","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B25917CF-6CA6-0EC7-E053-4EBD850AC41D","latestVersionIndicator":"Yes","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"MALUMK","dateModified":"2021-04-15","changeDescription":"Released. 01/28/2021 KMM; System generated def displayed as alt def. 10/23/2020 KMM. ALT name added for 4003r4. 04/15/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}